Toll-Like Receptor 2
Toll-like receptors (TLRs) are expressed in immune cells such as dendritic cells and macrophages and recognize pathogens (Takeda and Akira 2005). Along with four other TLRs, human TLR2 was first named and reported as a receptor similar to the Drosophila Toll protein in 1998 (Rock et al. 1998). TLR2 gene, with a size of 21,836 bases on chromosome 4, encodes the TLR2 protein. TLR2 is one of the pattern recognition receptors (PRRs) that sense pathogen-associated molecular patterns (PAMPs) of microbes and thus act as a first line of host defense (Janeway and Medzhitov 2002). The triggering of an innate immune response by PRRs after recognition of conserved microbial components and further development of the adaptive immunity were first described by Charles A. Janeway Jr. (Janeway 1989). The initial understanding of the TLR2 ligand was obtained in 1999 when a study revealed...
This work was supported by the National Research Foundation of Korea (NRF-2015R1A2A2A09001059).
- Arslan F, Houtgraaf JH, Keogh B, Kazemi K, de Jong R, McCormack WJ, et al. Treatment with OPN-305, a humanized anti-Toll-Like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs. Circ Cardiovasc Interv. 2012;5:279–87. https://doi.org/10.1161/CIRCINTERVENTIONS.111.967596.CrossRefPubMedPubMedCentralGoogle Scholar
- Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197–216. https://doi.org/10.1146/annurev.immunol.20.083001.084359.CrossRefPubMedPubMedCentralGoogle Scholar
- Lima CX, Souza DG, Amaral FA, Fagundes CT, Rodrigues IP, Alves-Filho JC, et al. Therapeutic effects of treatment with anti-TLR2 and anti-TLR4 monoclonal antibodies in polymicrobial sepsis. PLoS One. 2015;10:e0132336. https://doi.org/10.1371/journal.pone.0132336.CrossRefPubMedPubMedCentralGoogle Scholar
- Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A. 2000;97:13766–71. https://doi.org/10.1073/pnas.250476497.CrossRefPubMedPubMedCentralGoogle Scholar
- Ramasawmy R, Cunha-Neto E, Fae KC, Borba SC, Teixeira PC, Ferreira SC, et al. Heterozygosity for the S180 L variant of MAL/TIRAP, a gene expressing an adaptor protein in the Toll-like receptor pathway, is associated with lower risk of developing chronic Chagas cardiomyopathy. J Infect Dis. 2009;199:1838–45. https://doi.org/10.1086/599212.CrossRefPubMedPubMedCentralGoogle Scholar
- Yamashita T, Freigang S, Eberle C, Pattison J, Gupta S, Napoli C, et al. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring. Circ Res. 2006;99:e51–64. https://doi.org/10.1161/01.RES.0000244003.08127.cc.CrossRefPubMedPubMedCentralGoogle Scholar